RISANKIZUMAB LEVELS ARE SIGNIFICANTLY CORRELATED AND PREDICTIVE OF BIOMARKER REMISSION IN CROHN'S DISEASE
Stéphane Paul 1
Louis Waeckel 1
Louise Merle 1
Anne-Emmanuelle Berger 1
Anne-Sophie Peaucelle 1
Mathilde Barrau 1
Xavier Roblin 2
1 Hôpital Nord, Saint Etienne, France
2 University of St. Etienne, Saint Etienne, France
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]